Minireviews
Copyright ©The Author(s) 2023.
World J Gastrointest Surg. Sep 27, 2023; 15(9): 1879-1891
Published online Sep 27, 2023. doi: 10.4240/wjgs.v15.i9.1879
Table 1 Demographic data of observational studies on abdominal compartment syndrome with acute pancreatitis
Ref.
Country of origin
Type of study
Number of patients with ACS/total studied patients
Etiology of acute pancreatitis, n (%)
Age (yr), mean ± SD, median (IQR)
Female, n (%)
Husu et al[22], 2021FinlandRetrospective matched-case controlOA: 40/47 (85.1%). CG: 21/47 (44.7%)Alcohol: 85% (OA), 72% (CG). Biliary: 4.3% (OA), 14.9% (CG). HTG: 4.3% (OA), 2.1% (CG)OA: 49 (27-82). CG: 50 (18-78)OA: 10.6%. CG: 12.8%
Smit et al[12], 2016NetherlandsRetrospective13/29 (44.8%)Biliary: 40.7%. Alcohol: 22%55 ± 153 (23%)
Peng et al[11], 2016ChinaRetrospective273/273 (100%)Biliary: 41%. Alcohol: 30%. Post ERCP: 10%46 (17-78)26 (42.6%)
Davis et al[14], 2013CanadaRetrospective16/45 (35.6%)Biliary: 53%. Alcohol: 26.7%59 ± 139 (20%)
Boone et al[15], 2013United StatesRetrospective12/12 (100%)Biliary: 41.7%. Alcohol: 33.3%56 ± 131 (8.3%)
Leppäniemi et al[16], 2011FinlandRetrospective10/10 (100%)Alcohol: 9 (90%). Drug: 1 (10%)46 (33-61)1 (10%)
Deng et al[17], 2011ChinaRetrospective8/8 (100%)Alcohol: 8/851.5 (35-66)2 (25%)
Mentula et al[18], 2010FinlandRetrospective26/26 (100%)Alcohol: 81%. Drug: 8%. Post ERCP: 4%42 (35-49)3 (11.5%)
Chen et al[19], 2008ChinaRetrospective20/44 (45.5%)Biliary: 59.1%. Alcohol: 11.4%. HTG: 15.9%62.6 ± 11.121 (47.7%)
De Waele et al[20], 2005BelgiumProspective21/44 (47.7%)Biliary: 33%. Alcohol: 38%. HTG: 14%53 (45-68)16 (45.5%)
Tao et al[21], 2003ChinaRetrospective23/23 (100%)NA41(31-71)7 (33%)
Table 2 Demographic data of case reports or case series on abdominal compartment syndrome with acute pancreatitis
Ref.
Origin of study
Age (yr)/sex
Etiology of acute pancreatitis
Cumulative fluid balance after 24 h (mL)
Cumulative fluid balance after 48 h (mL)
IAP (mmHg) at diagnosis, after decompression
Organ support
Kawasaki et al[23], 2022Japan42/femaleAlcohol-use10000NA52, 30Mechanical ventilation, RRT
Lee et al[27], 2019Australia38/maleAlcohol-use600028, NAMechanical ventilation, vasopressors
Ikeda et al[28], 2019Japan65/femaleBiliaryNANA22, NAMechanical ventilation, vasopressors
McKenzie et al[31], 2017United States45/maleBiliaryNANA> 20, NARRT, mechanical ventilation
Simoneau et al[30], 2014Canada67/maleBiliaryNANANAMechanical ventilation
Jacob et al[29], 2016Australia30/maleAlcohol-use3930360031, NARRT, mechanical ventilation, vasopressors
Jacob et al[29], 2016Australia40/maleAlcohol-use4400360033, NARRT, mechanical ventilation, vasopressors
Jacob et al[29], 2016Australia32/femaleAlcohol-use4560370028, NAMechanical ventilation, vasopressors
Jacob et al[29], 2016Australia42/maleAlcohol-use2500750030, NARRT, mechanical ventilation, vasopressors
Jacob et al[29], 2016Australia28/maleAlcohol-use4200365028, NAMechanical ventilation, vasopressors
Siebig et al[25], 2008Germany56/maleOtherNANANAMechanical ventilation, vasopressors, ECMO
Siebig et al[25], 2008Germany49/maleBiliary100007000> 25, NAMechanical ventilation
Siebig et al[25], 2008Germany74/femalePost-surgeryNANA> 20, NAMechanical ventilation
De Waele et al[26], 2005Belgium37/maleAlcohol-useNANA27, NAMechanical ventilation
Hu et al[24], 2013China27/maleBiliaryNANA26, 15Mechanical ventilation
Hu et al[24], 2013China60/femaleHTGNANA25, 17Mechanical ventilation
Hu et al[24], 2013China45/femaleHTGNANA22, 14Mechanical ventilation
Table 3 Outcomes data from observational studies on abdominal compartment syndrome with acute pancreatitis
Ref.
IAP (mmHg), mean ± SD (range)
Organ dysfunction
Surgical decompression, including type of surgery
Time to intervention from hospitalization, diagnosis of ACS
Outcome
Post-decompressions complications
Pre-surgery
Post-surgery
Husu et al[22], 2021OA: 24 ± 4. CG: 21 ± 5NASOFA: OA: 13 (11-14); CG: 12 (10-15). APACHE II: OA: 23 (17-29); CG: 18 (15-26)ML in OA: 47/47 (100%)60 (36-175) h, NA90 d. mortality: OA: 19/40 (48%); CG: 3/21 (14%)
Smit et al[12], 201627 ± 318 ± 413/13 (100%). AKI: 100%. Respiratory failure: 100%. Shock: 100%10 (76.9%). ML: 3 (33%). Subcostal full-thickness laparostomy: 7 (67%)13.4 ± 6.5 d, 12 (2-176) hMortality: 7 (53.8%). LOS ICU: 48 d. GI ischemia: 61.5%Bowel perforation or fistula: 46.2%
Peng et al[11], 2016PCD: 31 (20-44). ML: 34 (20-51)PCD: 19 (3-40). ML: 15 (2-24)SOFA: PCD-11(2-23), ML-10 (3-24), decreased to 9 (2-24) and 9 (3-24)ML: 61/273 (22.3%). PCD: 212/273 (77.7%)PCD: 61 (2-101) h. ML: 64 (5-95) hMortality: PCD: 40 (19%); ML: 32 (52%). LOS hospital: 125 (21-627) d. LOS ICU: PCD: 14 d, ML: 21 d. Subsequent necrosectomy in PCD: 160 (75%), ML: 49 (80%)Hepatic/portal/superior mesenteric vein/splanchnic vein thrombosis: ML: 3.2%, PCD: 0.9%. Bleeding: ML: 11.4%, PCD: 3.8%. Fistula: ML: 24.6%, PCD:18.4%
Davis et al[14], 201329.5NAAKI: 5 (31.3%). Respiratory failure: 11 (68.8%)16 (35.6%). ML: 100%NA, 3.1 hMortality: 4 (25%). LOS hospital: 146 dFistula: 62.5%. Wound infection: 62.5%. Incisional Hernia: 50%
Boone et al[15], 201342NAMean APACHE: 23.3. Mean ranson: 912 (100%). ML: 12 (100%)< 7 d in 9 patients, NAMortality: 6 (50%). Among survivors: LOS ICU: 37 ± 13 d; LOS hospital: 40.5 ± 25.2 d; IMV: 28 ± 11.4 dInfection: 16%. Fistula: 16%
Leppäniemi et al[16], 201131 (23-45)11 (1-20)Mean SOFA: 12 (14-17)Subcutaneous linea alba fasciotomy: 10 (100%). Subsequently, four required completion laparostomy1-17 d (in 6 cases: < 48 h), NAMortality: 4 (40%). LOS hospital: 35 d; LOS ICU: 26 dHernia: 30%. Bleeding: 20%. Wound infection: 10%. Fistula: 10%
Deng et al[17], 201129 (23-38)7.5 (6-18)Resp failure: 8 (100%). AKI: 7 (87.5%). Hepatic: 7 (87.5%). Shock- 8 (100%)8 (100%). ML plus continuous regional arterial infusion with protease inhibitors and antibiotics via a drug delivery system3-9 d, NAMortality: 1(12.5%), LOS-ICU: 41 d, LOS-hospital- 117 dNot mentioned
Mentula et al[18], 201031.5 (27-35)NAResp failure: 24 (92%). AKI: 14 (54%). Shock: 23 (88%). Liver: 2 (8%)26 (100%). ML: 18 (69.2%). Bilateral subcostal laparostomy: 1 (3.8%). SLAF: 7, 2/7 finally laparostomy1 (0-29) d, NAMortality: 12/26 (46.2%)Intrabdominal infection: 73%. Fistula: 19%
Chen et al[19], 200836.7 ± 5.318.3 ± 3.3MODS: 18 (90%). Shock: 14 (70%)8 (65%). PCD: 5 (25%). ML: 5 (25%). Combined: 3 (15%)NA, 28.38 ± 2.29 hMortality: 15/20 (75%)No complications reported
De Waele et al[20], 2005> 25NAResp failure: 20 (98%). AKI: 18 (86%). Shock: 19 (94%)ML: 4/21. Indication for surgery: ACS: 4 (44.4%)3, < 24 hMortality: 3/4 (75%). LOS ICU: 21 (10-37) d. LOS hospital: 42 (20-90) d. IMV: 15 (12.6) dNo complications reported
Tao et al[21], 2003> 20NAResp. failure: 100%. Shock: 100%18/23 (78.2%). ML with drainage: 100%NA, 5-22 hMortality: 3/18 (16.7%). Definitive closures 3-5 dHemorrhage: 42%. Abscess: 19.2%. Perforation/fistula: 3.8%
Table 4 Demographic data of case reports or case series on abdominal compartment syndrome with acute pancreatitis
Ref.
Type of surgery
Timing of the laparotomy from the diagnosis or admission
Abdomen closed after laparotomy
Management of open abdomen
Duration of open abdomen (d)
Outcome
Duration of ICU stay (d)
Duration of hospital stay (d)
Complications
Kawasaki et al[23], 2022Midline fasciotomy4 dNoVAC7Alive29 53None
Lee et al[27], 2019Midline laparotomy24 hNoVAC75Alive44 121None
Ikeda et al[28], 2019Midline laparotomy4 hNoOpen with mesh2AliveNA104 None
McKenzie et al[31], 2017Midline laparotomy24 hNoVAC10AliveNANANone
Jacob et al[29], 2016Midline laparotomy5 hNoVAC21 AliveNA35 Pancreatic fistula: 4 (80%)
Jacob et al[29], 2016Midline laparotomy1 dNoVAC18 AliveNA54
Jacob et al[29], 2016Midline laparotomy4 dNoVAC15 Alive2243
Jacob et al[29], 2016Midline laparotomy2 dNoVAC18 Alive3049
Jacob et al[29], 2016Midline laparotomy2 dNoVAC10 Alive3262
Simoneau et al[30], 2014Midline laparotomy12 hNoVAC and vicryl mesh210Alive210300Pancreatic fistula
Hu et al[24], 2013Transverse laparotomyNANANANAAliveNA71 None
Hu et al[24], 2013Transverse laparotomyNANANANAAliveNA54 None
Hu et al[24], 2013Transverse laparotomyNANANANAAliveNA31 None
Siebig et al[25], 2008Midline laparotomy1 dYesNANAAliveNANANone
Siebig et al[25], 2008Midline laparotomy1 dNoVACNADeathNANALung hemorrhage
Siebig et al[25], 2008Midline laparotomy< 24 hNoVAC90AliveNANANone
De Waele et al[26], 2005Midline laparotomy24 hNoVAC29AliveNANAIntraabdominal infection